Bioventus Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Bioventus Inc inventory turnover ratio, the Bioventus Inc 's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 2.24 in the third quarter 2026, BVS's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Bioventus Inc in Sep 26 2026 quarter, has decreased to 163 days, compare to 171 days, in the Jun 27 2026 quarter.

Within Healthcare sector 177 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 925 in the second quarter 2026, to 1566.

BVS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Bioventus Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BVS Inventory Turnover Ratio	(Sep 26 2026) III. Quarter	(Jun 27 2026) II. Quarter	(Mar 28 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 27 2025) III. Quarter
Y / Y Inventory Growth	-13.69 %	-17.27 %	-11.55 %	-11.07 %	6.93 %
Y / Y Cost of Sales Growth	2.99 %	4.33 %	2.5 %	-3.85 %	-2.22 %
Inventory Turnover Ratio (TTM)	2.24	2.14	2.02	1.95	1.92
BVS's Total Ranking	# 1566	# 925	# 1054	# 992	#
Average inventory processing period	163	171	181	188	191
Seq. Inventory Growth	4.12 %	-4.06 %	1.16 %	-14.58 %	-0.2 %
Seq. Cost of Sales Growth	-4.69 %	15.96 %	-18 %	13.64 %	-3.45 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 74
Healthcare Sector	# 178
Overall Market	# 1566

Inventory Turnover Ratio Statistics
High	Average	Low
2.98	2.12	0.4
(Apr 02 2022)		(Apr 03 2021)

BVS Company Profile >> Back to BVS Efficiency Comparisons >> Compare BVS Inventory Turnover Ratio to its Competitors

Financial Statements
Bioventus Inc 's Inventories	$ 83 Millions	Visit BVS's Balance sheet
Bioventus Inc 's Cost of Revenues TTM	$ 184 Millions	Visit BVS's Income Statement
What are BVS's Sales?		Visit BVS's Sales by Segment

Other Inventory Turnover Ratios
Bioventus Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BVS's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BVS's Competitors
Inventory Turnover Ratio for BVS's Suppliers
Inventory Turnover Ratio for BVS's Customers

You may also want to know
BVS's Sales Growth Rates	BVS's Pe Price to earnings ratio	BVS's Receivables Turnover Ratio	BVS's Stock Quote
BVS's Net Income Growth Rates	BVS's Ps Price to Sales ratio	BVS's Sales per Employee	BVS's Asset Turnover Ratio
BVS's Net Margin	BVS's Pb Price to Book ratio	BVS's Financial Strength Ratios	BVS's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Sep 26 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Sep 26 2026	Inventories at quarter ending Sep 26 2026
Bristol myers Squibb Company	5.65	$ 15,389.000 Millions	$ 2,722 Millions
Avantor Inc	5.48	$ 4,539.200 Millions	$ 828 Millions
Tactile Systems Technology Inc	5.25	$ 82.718 Millions	$ 16 Millions
Integer Holdings Corporation	4.98	$ 1,376.268 Millions	$ 276 Millions
Ge Healthcare Technologies Inc	4.69	$ 11,372.000 Millions	$ 2,425 Millions
West Pharmaceutical Services Inc	4.69	$ 2,120.200 Millions	$ 452 Millions
Idexx Laboratories Inc	4.52	$ 1,743.379 Millions	$ 386 Millions
Medinotec Inc	4.28	$ 5.143 Millions	$ 1 Millions
3m Company	4.02	$ 15,267.000 Millions	$ 3,801 Millions
Novocure Limited	3.98	$ 166.721 Millions	$ 42 Millions
Incyte Corporation	3.79	$ 439.399 Millions	$ 116 Millions
Baxter International Inc	3.57	$ 8,117.000 Millions	$ 2,277 Millions
Bausch Health Companies Inc	3.54	$ 4,518.000 Millions	$ 1,276 Millions
Exelixis Inc	3.49	$ 93.324 Millions	$ 27 Millions
Gilead Sciences Inc	3.30	$ 6,219.000 Millions	$ 1,884 Millions
Mimedx Group Inc	2.98	$ 70.562 Millions	$ 24 Millions
Ligand Pharmaceuticals Incorporated	2.93	$ 34.495 Millions	$ 12 Millions
Neogen Corporation	2.89	$ 464.774 Millions	$ 161 Millions
Biomerica Inc	2.65	$ 4.297 Millions	$ 2 Millions
Dexcom Inc	2.65	$ 1,867.500 Millions	$ 705 Millions
Angiodynamics Inc	2.50	$ 142.709 Millions	$ 57 Millions
Pro dex Inc	2.45	$ 53.753 Millions	$ 22 Millions
Illumina Inc	2.36	$ 1,458.000 Millions	$ 618 Millions
Resmed Inc	2.33	$ 2,214.675 Millions	$ 952 Millions
Beta Bionics Inc	2.31	$ 53.285 Millions	$ 23 Millions
Merit Medical Systems Inc	2.25	$ 817.001 Millions	$ 363 Millions
Bioventus Inc	2.24	$ 183.856 Millions	$ 82 Millions
Johnson and Johnson	2.17	$ 32,222.000 Millions	$ 14,824 Millions
Glaukos Corp	2.13	$ 131.180 Millions	$ 62 Millions
Organon and Co	2.08	$ 2,859.000 Millions	$ 1,371 Millions

Date modified: 2026-11-03T16:39:58+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.